Welcome to LookChem.com Sign In|Join Free
  • or
1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(pyridin-3-yl)propane-1,3-dione is a chemical compound with the formula C18H17NO5, derived from curcumin, a natural compound found in turmeric. It possesses anti-inflammatory and antioxidant properties, making it a potential pharmaceutical compound for treating various diseases such as cancer, diabetes, and neurological disorders. Its structure, which includes a hydroxyphenyl group and a pyridinyl group, is believed to contribute to its biological activities. Further research is needed to fully understand the potential therapeutic applications of 1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(pyridin-3-yl)propane-1,3-dione.

6344-87-2

Post Buying Request

6344-87-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6344-87-2 Usage

Uses

Used in Pharmaceutical Applications:
1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(pyridin-3-yl)propane-1,3-dione is used as a potential therapeutic agent for various diseases due to its anti-inflammatory and antioxidant properties. Its application in treating cancer, diabetes, and neurological disorders is currently under investigation.
Used in Research and Development:
In the field of pharmaceutical research and development, 1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(pyridin-3-yl)propane-1,3-dione serves as a valuable compound for studying its potential therapeutic applications and understanding its biological activities. This research may lead to the development of new drugs and treatment options for various diseases.
Used in Antioxidant and Anti-inflammatory Applications:
1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(pyridin-3-yl)propane-1,3-dione is used as an antioxidant and anti-inflammatory agent, potentially benefiting conditions where oxidative stress and inflammation play a significant role in disease progression.
Used in Cancer Treatment Research:
In the field of oncology, 1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(pyridin-3-yl)propane-1,3-dione is used as a compound for investigating its potential role in cancer treatment, particularly in targeting specific cancer-related pathways and enhancing the efficacy of conventional chemotherapeutic drugs.
Used in Drug Delivery Systems:
1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(pyridin-3-yl)propane-1,3-dione may be used in the development of novel drug delivery systems to improve its bioavailability and therapeutic outcomes, particularly in the context of cancer treatment. Various organic and metallic nanoparticles could be employed as carriers for 1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(pyridin-3-yl)propane-1,3-dione, aiming to enhance its delivery and efficacy against cancer cells.

Check Digit Verification of cas no

The CAS Registry Mumber 6344-87-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,4 and 4 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 6344-87:
(6*6)+(5*3)+(4*4)+(3*4)+(2*8)+(1*7)=102
102 % 10 = 2
So 6344-87-2 is a valid CAS Registry Number.

6344-87-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2-hydroxy-4,6-dimethoxyphenyl)-3-pyridin-3-ylpropane-1,3-dione

1.2 Other means of identification

Product number -
Other names 1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(pyridin-3-yl)propane-1,3-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6344-87-2 SDS

6344-87-2Relevant academic research and scientific papers

Novel synthesised flavone derivatives provide significant insight into the structural features required for enhanced anti-proliferative activity

Ravishankar, Divyashree,Watson, Kimberly A.,Greco, Francesca,Osborn, Helen M. I.

, p. 64544 - 64556 (2016/07/21)

With many cancers showing resistance to current chemotherapies, the search for novel anti-cancer agents is attracting considerable attention. Natural flavonoids have been identified as useful leads in such programmes. However, since an in-depth understanding of the structural requirements for optimum activity is generally lacking, further research is required before the full potential of flavonoids as anti-proliferative agents can be realised. Herein a broad library of 76 methoxy and hydroxy flavones, and their 4-thio analogues, was constructed and their structure-activity relationships for anti-proliferative activity against the breast cancer cell lines MCF-7 (ER +ve), MCF-7/DX (ER +ve, anthracycline resistant) and MDA-MB-231 (ER -ve) were probed. Within this library, 42 compounds were novel, and all compounds were afforded in good yields and >95% purity. The most promising lead compounds, specifically the novel hydroxy 4-thioflavones 15f and 16f, were further evaluated for their anti-proliferative activities against a broader range of cancer cell lines by the National Cancer Institute (NCI), USA and displayed significant growth inhibition profiles (e.g. compound-15f: MCF-7 (GI50 = 0.18 μM), T-47D (GI50 = 0.03 μM) and MDA-MB-468 (GI50 = 0.47 μM) and compound-16f: MCF-7 (GI50 = 1.46 μM), T-47D (GI50 = 1.27 μM) and MDA-MB-231 (GI50 = 1.81 μM)). Overall, 15f and 16f exhibited 7-46 fold greater anti-proliferative potency than the natural flavone chrysin (2d). A systematic structure-activity relationship study against the breast cancer cell lines highlighted that free hydroxyl groups and the B-ring phenyl groups were essential for enhanced anti-proliferative activities. Substitution of the 4-CO functionality with a 4-CS functionality, and incorporation of electron withdrawing groups at C-4′ of the B-ring phenyl, also enhanced activity. Molecular docking and mechanistic studies suggest that the anti-proliferative effects of flavones 15f and 16f are mediated via ER-independent cleavage of PARP and downregulation of GSK-3β for MCF-7 and MCF-7/DX cell lines. For the MDA-MB-231 cell line, restoration of the wild-type p53 DNA binding activity of mutant p53 tumour suppressor gene was indicated.

Design, synthesis, biological evaluation, and molecular docking of novel benzopyran and phenylpyrazole derivatives as Akt inhibitors

Zhan, Wenhu,Lin, Sendong,Chen, Jing,Dong, Xiaowu,Chu, Jianbo,Du, Wenting

, p. 770 - 779 (2015/05/27)

By inspiration of good Akt1 inhibitory and cytotoxic activity of our previously screened hits 1 and 2, a series of novel benzopyrans 3a-c, 4 and phenylpyrazoles 5a-c, 6a-b, and 7 were designed, synthesized, and biologically evaluated for their in vitro Ak

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 6344-87-2